Karikehalli, Shridevi
Mayo Clinic
Department of Pathology and Laboratory Medicine, Centrex Clinical Laboratories, Utica, NY;
Citations 1
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Castellar, Edgardo R. Parrilla , Jaffe, Elaine S. , Said, Jonathan , Ketterling, Rhett P. , Knudson, Ryan A., Sidhu, Jagmohan S. , Karikehalli, Shridevi, Jiang, Liuyan , Vasmatzis, George , Ondrejka, Sarah L. , Nicolae, Alina , Grogg, Karen L., Allmer, Cristine, Ristow, Kay M., Wilson, Wyndham H. , Macon, William R. , Cerhan, James R. , Ansell, Stephen M. , Maurer, Matthew J. , Feldman, Andrew L. , Parrilla Castellar, Edgardo R, Law, Mark E. , Doǧan, Ahmet , Feldman, Andrew L , Swerdlow, Steven H. , Hsi, Eric D. , Gibson, Sarah E. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Jaffe, Elaine S , Ketterling, Rhett P
Blood | June 3, 2014 | Volume: 124 | Issue: 9 | Pages: 1473-1480
Key Points ALK-negative ALCLs have chromosomal rearrangements of DUSP22 or TP63 in 30% and 8% of cases, respectively. DUSP22-rearranged cases have favorable outcomes similar to ALK-positive ALCLs, whereas other genetic subtypes have inferior outcomes.